Avoro Capital Advisors’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,000,000
| Closed | -$18.4M | – | 47 |
|
|
2023
Q3 | $18.4M | Sell |
3,000,000
-60,000
| -2% | -$368K | 0.29% | 33 |
|
|
2023
Q2 | $19.2M | Hold |
3,060,000
| – | – | 0.26% | 34 |
|
|
2023
Q1 | $14.6M | Hold |
3,060,000
| – | – | 0.22% | 33 |
|
|
2022
Q4 | $26.6M | Hold |
3,060,000
| – | – | 0.4% | 30 |
|
|
2022
Q3 | $36.4M | Sell |
3,060,000
-40,000
| -1% | -$476K | 0.67% | 24 |
|
|
2022
Q2 | $44.2M | Buy |
3,100,000
+900,000
| +41% | +$12.8M | 0.87% | 21 |
|
|
2022
Q1 | $45.8M | Buy |
2,200,000
+735,000
| +50% | +$15.3M | 0.84% | 21 |
|
|
2021
Q4 | $33.8M | Sell |
1,465,000
-1,460,000
| -50% | -$33.7M | 0.58% | 29 |
|
|
2021
Q3 | $87.2M | Buy |
2,925,000
+1,100,000
| +60% | +$32.8M | 1.37% | 18 |
|
|
2021
Q2 | $62.3M | Sell |
1,825,000
-535,267
| -23% | -$18.3M | 1.08% | 20 |
|
|
2021
Q1 | $77.6M | Buy |
2,360,267
+10,000
| +0.4% | +$329K | 1.34% | 17 |
|
|
2020
Q4 | $131M | Buy |
2,350,267
+500,267
| +27% | +$27.8M | 2.25% | 15 |
|
|
2020
Q3 | $57.6M | Buy |
+1,850,000
| New | +$57.6M | 0.82% | 24 |
|